Citadel Advisors’s GMO Systematic Investment Grade Credit ETF INVG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Sell
10,065
-3,000
-23% -$76.3K ﹤0.01% 11491
2026
Q1
$330K Buy
+13,065
New +$335K ﹤0.01% 10265
2025
Q4
Sell
-15,551
Closed -$402K 14625
2025
Q3
$402K Sell
15,551
-2,723
-15% -$69.8K ﹤0.01% 9659
2025
Q2
$467K Buy
+18,274
New +$462K ﹤0.01% 8792

Other funds holding INVG

Citadel Advisors's INVG Position: Q2 2026 in Review

Citadel Advisors reduced its GMO Systematic Investment Grade Credit ETF (INVG) stake by 23% in Q2 2026, selling an estimated $76.3K and leaving 10,065 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #11491.

Citadel Advisors first reported a position in INVG in Q2 2025 and has held it in 4 quarters since. The position peaked at $467K in Q2 2025. 6 funds tracked by Wall St. Rank hold INVG as of Q2 2026.

  • Citadel Advisors held 10,065 shares of GMO Systematic Investment Grade Credit ETF worth $256K as of Q2 2026.
  • Citadel Advisors sold 3,000 GMO Systematic Investment Grade Credit ETF shares in Q2 2026, an estimated $76.3K.
  • GMO Systematic Investment Grade Credit ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11491 holding.
  • Citadel Advisors first reported a position in GMO Systematic Investment Grade Credit ETF in Q2 2025 and has held it in 4 quarters since.
  • Citadel Advisors's GMO Systematic Investment Grade Credit ETF position peaked at $467K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held GMO Systematic Investment Grade Credit ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.